Events and resources

Patient resources

Cholangiocarcinoma (CCA) is a rare cancer¹ and there are few resources directed at patients, therefore a diagnosis of CCA can be worrying and confusing. Help your patients navigate through the uncertainty by providing them with resources about their disease

Listen to Professor Jesús Bañales describe the devastating impact of CCA and how access to specifically tailored CCA resources can benefit your patients. Please note, available resources vary by country

REFERENCE: 1. Bañales JM, et al. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.

Click on a patient resource to learn more

Please do not share this page with patients directly

Clinical advances in the treatment of CCA

Supported by an independent educational grant from Incyte, ‘Clinical advances in the treatment of CCA’ is a Medscape educational initiative that provides a broad range of Continuing Medical Education (CME)-accredited activities to inform on the identification, diagnosis and treatment of patients with CCA. The fifth and final activity is now live and educates healthcare professionals on best practice treatment of advanced/metastatic CCA through interactive case studies and expert perspectives

View resource

Key publications

Incyteful for you

Incyteful is an Incyte platform that offers CCA medical education and events relevant to your daily practice

Incyteful is your one-stop resource for:

Interactive eLearning modules

Expert perspectives on CCA

Symposia highlights

Educational webinars

Informative brochures and more!

Disclosures

Professor Jesús Bañales:

Company/Organisation	Relationship(s)
Albireo Pharma, CIMABay, Ikan Biotech, OWL Metabolomics, QED Therapeutics	Consulting/advisory role
Incyte, Intercept	Honoraria/lectures
Albireo, Incyte, Roche	Research funding

‘Understanding your cholangiocarcinoma’ booklet

Patients diagnosed with cholangiocarcinoma (CCA) are likely to have many questions. This booklet supports patients by answering questions they may have regarding CCA, its diagnosis and management, and molecular profiling.

Download resource

Listen to Helen Morement (CEO and Founder of AMMF – The Cholangiocarcinoma Charity) describe the ‘Understanding your cholangiocarcinoma’ booklet.

Helen Morement

CEO and Founder of AMMF - The Cholangiocarcinoma Charity, London, UK

Disclosures: Helen Morement

Company/Organisation	Relationship(s)
Incyte	Speaker

‘Molecular testing in cholangiocarcinoma’ booklet

Genomic analysis of patients with cholangiocarcinoma has revealed genomic alterations with potential therapeutic implications in ~50% of patients.¹ This booklet helps patients to understand why and how molecular testing is performed and the role it may play in guiding treatment decisions. Example questions about molecular testing are included to prompt patients to think of questions that they may wish to ask their treatment team.

REFERENCE: 1. Lowery MA, et al. Clin Cancer Res. 2018;24:4154–61.

Download resource

Listen to Helen Morement (CEO and Founder of AMMF – The Cholangiocarcinoma Charity) describe the ‘Molecular testing in cholangiocarcinoma’ booklet.

Helen Morement

CEO and Founder of AMMF - The Cholangiocarcinoma Charity, London, UK

Disclosures: Helen Morement

Company/Organisation	Relationship(s)
Incyte	Speaker

AMMF resources

AMMF – The Cholangiocarcinoma Charity – works across Europe and actively collaborates globally. The AMMF European cholangiocarcinoma (CCA) website, available in 9 languages, supports patients and their carers/loved ones seeking information on all aspects of CCA across Europe; it also helps healthcare practitioners, including clinical nurse specialists, to navigate information available for their patients with CCA.

View resource

Listen to Helen Morement (CEO and Founder of AMMF – The Cholangiocarcinoma Charity) describe the AMMF resources available.

Helen Morement

CEO and Founder of AMMF - The Cholangiocarcinoma Charity, London, UK

Disclosures: Helen Morement

Company/Organisation	Relationship(s)
Incyte	Speaker

Events and resources

Patient resources

Click on a patient resource to learn more

Clinical advances in the treatment of CCA

Key publications

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Cholangiocarcinoma 2020: The next horizon in mechanisms and management

Management of intrahepatic cholangiocarcinoma

Promising molecular targets for the targeted therapy of biliary tract cancers: An overview

Practical considerations in screening for genetic alterations in cholangiocarcinoma

Biliary tract cancer

Incyteful for you